Premium
TPG Growth, the mid-market and growth equity platform of private equity firm TPG, has bet on a bulk-drugs company in the investment group’s second deal in the pharmaceutical sector within six months. TPG Growth is infusing Rs 200 crore ($28 million) into Solara Active Pharma Sciences Ltd. It would pick up ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
